By Counterforce Health Team in Cosentyx (secukinumab) —

Myths vs. Facts: Getting Cosentyx (secukinumab) Covered by Cigna in Ohio - Complete Appeals Guide

Answer Box: Getting Cosentyx (secukinumab) Covered by Cigna in Ohio

Fastest Path to Approval: Submit Cigna's prior authorization form with complete TB screening, documented step therapy (methotrexate or other systemic agent failure), objective severity scores (PASI/BSA for psoriasis, BASDAI for ankylosing spondylitis), and specialist prescriber attestation. If denied, file internal appeal within 180 days, then external review through Ohio Department of Insurance. First step today: Call Cigna member services to confirm your plan's specific Cosentyx criteria and formulary status.

Table of Contents

  1. Why Myths About Cigna Coverage Persist
  2. Myth vs. Fact: Common Misconceptions
  3. What Actually Influences Cosentyx Approval
  4. Avoid These Critical Mistakes
  5. Quick Action Plan: 3 Steps to Take Today
  6. Ohio-Specific Appeals Process
  7. Resources and Support

Why Myths About Cigna Coverage Persist

Misinformation about getting Cosentyx (secukinumab) covered by Cigna spreads quickly—often from outdated experiences, plan variations, or incomplete understanding of prior authorization requirements. These myths can delay treatment and waste valuable appeal opportunities.

The reality? Cigna's coverage policies for Cosentyx are detailed but navigable when you understand the specific criteria. In Ohio, where external review laws provide strong consumer protections, well-documented appeals have meaningful success rates.

Understanding the facts—not the myths—can mean the difference between months of delays and prompt approval for this important biologic therapy.

Myth vs. Fact: Common Misconceptions

Myth 1: "If my doctor prescribes Cosentyx, Cigna has to cover it"

Fact: Cigna requires prior authorization for Cosentyx with specific medical necessity criteria. Simply having a prescription isn't enough—you need documented failure of conventional therapies, appropriate TB screening, and specialist involvement.

Myth 2: "Appeals rarely work, so don't bother trying"

Fact: Over 80% of prior authorization appeals are overturned when patients actually file them. The problem? Only about 10% of denials are appealed. In Ohio, the external review process provides an additional safety net through independent medical experts.

Myth 3: "I have to try every other biologic before Cosentyx"

Fact: Cigna's Cosentyx policy requires trial of "at least one traditional systemic agent" (like methotrexate, cyclosporine, or phototherapy) for 3+ months, unless contraindicated. It doesn't mandate trying all other biologics first, though your specific plan may have additional step therapy requirements.

Myth 4: "TB tests from years ago are fine"

Fact: Cigna typically requires recent TB screening before Cosentyx approval. The policy references baseline TB testing as part of safety requirements. Using outdated results is a common denial reason that's easily preventable.

Myth 5: "Primary care doctors can't prescribe Cosentyx"

Fact: While Cigna's policy requires prescribing "by or in consultation with a dermatologist" for psoriasis, this allows for collaborative care arrangements. The key is documented specialist involvement, not necessarily direct prescribing.

Myth 6: "Non-formulary drugs are never covered"

Fact: Cigna has a formulary exception process that allows coverage of non-formulary drugs when medically necessary. You need prescriber attestation that formulary alternatives were ineffective, caused adverse effects, or are contraindicated.

Myth 7: "Ohio doesn't have good appeal rights"

Fact: Ohio provides robust external review protections with 180 days to request external review and binding decisions from independent medical experts. The Ohio Department of Insurance can even order external review if insurers wrongly claim ineligibility.

Myth 8: "Expedited appeals are only for emergencies"

Fact: Expedited review is available when delays would "seriously jeopardize life, health, or ability to regain maximum function"—which can include disease flares, functional decline, or risk of permanent damage from untreated autoimmune conditions.

What Actually Influences Cosentyx Approval

Understanding Cigna's real decision-making criteria helps you build a stronger case:

Core Documentation Requirements

Requirement What Cigna Looks For Source
Diagnosis Moderate-to-severe plaque psoriasis, PsA, AS, or other approved indication Cigna Policy
Prescriber Dermatologist for psoriasis; rheumatologist for arthritis conditions Cigna Policy
Prior Therapy ≥3 months trial of traditional systemic agent, unless contraindicated Cigna Policy
TB Screening Recent IGRA or TST results with interpretation Cigna Policy
Severity Measures PASI/BSA for psoriasis; joint counts/BASDAI for arthritis Clinical guidelines

Plan-Specific Variations

Your specific Cigna plan may have additional requirements:

  • Step therapy through preferred biologics
  • Quantity limits on dosing frequency
  • Site of care restrictions (office vs. home administration)
  • Age restrictions beyond FDA labeling
Tip: Call Cigna member services to request your plan's specific Cosentyx criteria before starting the PA process.

Avoid These Critical Mistakes

1. Incomplete TB Screening Documentation

The Problem: Missing or outdated TB test results are among the most common denial reasons for biologics.

The Fix: Order fresh IGRA (interferon-gamma release assay) or TST within 12 weeks of planned Cosentyx start. Include the lab report, not just a note saying "TB negative."

2. Weak Step Therapy Documentation

The Problem: Vague statements like "failed multiple DMARDs" without specifics.

The Fix: Create a detailed medication timeline with:

  • Drug names and doses
  • Start and stop dates
  • Duration of trial (≥3 months when possible)
  • Specific reasons for discontinuation (ineffective, adverse effects, contraindications)

3. Missing Objective Severity Scores

The Problem: Narrative descriptions of "severe disease" without measurable data.

The Fix: Document specific scores:

  • Psoriasis: PASI score, body surface area (BSA) percentage, DLQI
  • Psoriatic arthritis: Joint counts, BASDAI, functional assessments
  • Ankylosing spondylitis: BASDAI, ASDAS, imaging findings

4. Wrong Prescriber Type

The Problem: PA submitted by primary care without documented specialist involvement.

The Fix: Ensure appropriate specialist (dermatologist, rheumatologist) is prescribing or clearly co-managing care with documented consultation.

5. Late Appeal Filing

The Problem: Missing Ohio's 180-day deadline for external review requests.

The Fix: Mark your calendar immediately upon receiving any denial. File appeals promptly—ideally within days, not months.

Quick Action Plan: 3 Steps to Take Today

Step 1: Verify Your Plan's Cosentyx Requirements

Who does it: You (the patient)
Time needed: 15-20 minutes
What to do:

  • Call Cigna member services (number on your ID card)
  • Ask specifically about Cosentyx coverage, formulary tier, and any step therapy requirements
  • Request they email or mail your plan's specific prior authorization criteria

Script: "I need to understand my plan's requirements for Cosentyx coverage. Can you tell me if it requires prior authorization, what the step therapy requirements are, and send me the specific criteria?"

Step 2: Gather Complete Medical Documentation

Who does it: You and your healthcare team
Time needed: 1-2 weeks
What to collect:

  • Recent specialist notes (within 3-6 months)
  • Complete medication history with outcomes
  • Fresh TB screening results
  • Objective severity scores
  • Any relevant lab work or imaging

Pro tip: Counterforce Health can help organize this documentation and ensure it aligns with Cigna's specific requirements.

Step 3: Submit Complete Prior Authorization

Who does it: Your prescriber's office
Time needed: 5-10 business days for decision
What to include:

  • Completed Cigna PA form
  • Medical necessity letter addressing each criterion
  • All supporting documentation
  • Clear contact information for follow-up questions

Follow-up: Call Cigna after 3-5 business days to confirm receipt and check status.

Ohio-Specific Appeals Process

If Cigna denies your Cosentyx prior authorization, Ohio law provides multiple appeal levels:

Internal Appeals with Cigna

Timeline: Generally 180 days from denial to file
Decision deadline: 30 days for standard, 72 hours for expedited
How to file: Use Cigna's appeal form or written request

External Review Through Ohio Department of Insurance

Eligibility: After exhausting Cigna's internal appeals
Timeline: 180 days from Cigna's final denial
Process: Request through Cigna, who notifies Ohio Department of Insurance
Decision timeline: 30 days standard, 72 hours expedited
Outcome: Binding on Cigna if favorable

Important: Ohio's external review is conducted by independent medical experts and has meaningful overturn rates, especially for well-documented specialty drug cases.

When to Request Expedited Review

Request expedited review if delay would:

  • Seriously jeopardize your life or health
  • Risk permanent functional loss
  • Worsen an ongoing autoimmune flare
  • Interrupt a current course of Cosentyx treatment

Contact for help: Ohio Department of Insurance Consumer Services: 1-800-686-1526

Resources and Support

Official Resources

Patient Advocacy

Counterforce Health specializes in turning insurance denials into evidence-backed appeals. Their platform helps identify denial reasons and draft targeted rebuttals using the right medical evidence and payer-specific criteria.

Financial Assistance

  • Novartis Patient Assistance: Income-based support programs
  • Cosentyx Copay Card: Reduces out-of-pocket costs for eligible patients
  • State Pharmacy Assistance Programs: Check Ohio-specific options

Disclaimer: This information is for educational purposes only and is not medical or legal advice. Coverage decisions depend on your specific plan and medical circumstances. Always consult your healthcare provider about treatment options and contact your insurance company or the Ohio Department of Insurance for official guidance on appeals processes.

Sources & Further Reading

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.